Celldex Therapeutics Inc

NEW
STU:TCE2 (USA)  
€ 33.83 +0.050 (+0.15%) Sep 2
At Loss
P/B:
4.34
Market Cap:
€ 2.67B ($ 3.10B)
Enterprise V:
€ 2.06B ($ 2.39B)
Volume:
50.00
Avg Vol (2M):
90.00
Trade In:

Celldex Therapeutics Inc (STU:TCE2) Dividend

Celldex Therapeutics Inc (STU:TCE2) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -12.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:TCE2 Dividend

Does Celldex Therapeutics Inc (STU:TCE2) pay a dividend?

Celldex Therapeutics Inc (STU:TCE2) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Celldex Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Celldex Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -12.1% over the past 3 years.

What are dividend-paying alternatives to Celldex Therapeutics Inc?

For dividend-paying alternatives in Celldex Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.